Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
17.67 USD | +0.06% | +10.99% | +21.28% |
Mar. 29 | Celcuity Inc. Enters into Second Amendment to its Existing Loan and Security Agreement | CI |
Mar. 28 | Craig Hallum Adjusts Celcuity Price Target to $25 From $20, Maintains Buy Rating | MT |
Chart calendar Celcuity Inc.
Upcoming events on Celcuity Inc.
Past events on Celcuity Inc.
2024-04-17 10:00 am | Stifel Virtual Targeted Oncology Days Conference - Fireside Chat |
2024-04-11 02:15 pm | Needham Healthcare Conference - Fireside Chat |
2024-03-27 04:30 pm | Q4 2023 Earnings Call |
2024-03-27 04:01 pm | Q4 2023 Earnings Release |
2024-03-13 08:40 am | Leerink Partners Global Biopharma Conference |
2024-03-06 02:10 pm | TD Cowen Health Care Conference - Fireside Chat |
2023-12-06 01:00 pm | San Antonio Breast Cancer Symposium - PO1-24-04 |
2023-11-29 12:30 pm | Evercore ISI HealthCONx Conference |
2023-11-16 04:00 am | Jefferies London Healthcare Conference |
2023-11-14 04:10 pm | Stifel Healthcare Conference |
2023-11-13 08:00 am | Q3 2023 Earnings Call |
2023-11-13 07:05 am | Q3 2023 Earnings Release |
2023-09-21 10:00 am | Investor Meeting |
2023-08-10 04:30 pm | Q2 2023 Earnings Call |
2023-08-10 04:00 pm | Q2 2023 Earnings Release |
2023-08-06 | BTIG Virtual Biotechnology Conference |
2023-06-09 12:15 pm | Jefferies Global Healthcare Conference |
2023-05-30 | Craig-Hallum Institutional Investor Conference |
2023-05-15 04:30 pm | Q1 2023 Earnings Call |
2023-05-15 04:00 pm | Q1 2023 Earnings Release |
Annual results
Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 5,04 |
EBITDA Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 -66,5 - | 0,00 |
EBIT Million USD | Released Forecast Spread | -6,76 -7,60 10.98% | -9,56 -9,50 -0.56% | -28,4 -28,0 -1.15% | -39,4 -38,9 -1.34% | -66,2 -65,1 -1.74% | -89,3 |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -7,36 -7,52 2.14% | -9,47 -9,46 -0.16% | -29,6 -29,3 -1.09% | -40,4 -40,0 -0.98% | -63,8 -62,8 -1.63% | -83,5 |
Net income Million USD | Released Forecast Spread | -7,36 -7,52 2.14% | -9,47 -9,46 -0.16% | -29,6 -29,1 -1.78% | -40,4 -40,0 -0.98% | -63,8 -62,8 -1.63% | -86,4 |
EPS USD | Released Forecast Spread | -0,72 -0,74 2.7% | -0,92 -0,93 0.54% | -2,21 -2,12 -4.12% | -2,64 -2,01 -31.51% | -2,69 -2,78 3.18% | -2,89 |
Announcement Date | 13/03/20 | 16/02/21 | 23/03/22 | 23/03/23 | 27/03/24 | - |
Quarterly results
Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 | 0,00 | 1,51 | 3,53 | 0,00 |
EBITDA Million USD | Released Forecast Spread | -12,5 -13,7 8.73% | -15,0 -14,6 -2.86% | -18,9 -17,1 -10.32% | -20,0 | ||||||||||
EBIT Million USD | Released Forecast Spread | -6,32 -6,01 -5.19% | -7,51 -6,86 -9.38% | -9,60 -7,94 -20.84% | -10,6 -9,93 -7.2% | -11,6 -11,1 -4.8% | -12,5 -13,2 5.13% | -15,1 -13,7 -9.52% | -18,9 -16,1 -17.14% | -19,7 -19,9 1.1% | -20,9 | -22,1 | -23,2 | -23,3 | -20,3 |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -6,75 -6,41 -5.35% | -7,93 -6,67 -18.99% | -9,96 -8,10 -22.99% | -10,9 -10,1 -8.22% | -11,6 -11,2 -3.52% | -11,9 -13,5 11.5% | -14,6 -14,2 -2.65% | -18,4 -16,4 -12.39% | -18,8 -19,1 1.09% | -20,6 | -21,9 | -23,1 | -23,2 | -20,5 |
Net income Million USD | Released Forecast Spread | -6,75 -6,22 -8.6% | -7,93 -7,05 -12.47% | -9,96 -8,23 -21.09% | -10,9 -10,2 -6.67% | -11,6 -11,2 -3.52% | -11,9 -13,5 11.5% | -14,6 -14,2 -2.65% | -18,4 -16,4 -12.39% | -18,8 -19,0 0.93% | -20,1 | -21,5 | -23,1 | -23,2 | -20,5 |
EPS USD | Released Forecast Spread | -0,45 -0,38 -18.42% | -0,53 -0,47 -12.17% | -0,67 -0,50 -33.33% | -0,75 -0,58 -28.76% | -0,69 -0,44 -57.71% | -0,55 -0,52 -6.28% | -0,66 -0,60 -10.46% | -0,83 -0,68 -21.61% | -0,65 -0,73 10.75% | -0,70 | -0,73 | -0,76 | -0,70 | -0,77 |
Announcement Date | 23/03/22 | 16/05/22 | 11/08/22 | 10/11/22 | 23/03/23 | 15/05/23 | 10/08/23 | 13/11/23 | 27/03/24 | - | - | - | - | - |
Past sector events for Celcuity Inc.
2024-05-03 07:00 am | GH RESEARCH PLC: Q1 2024 Earnings Release |
2024-05-02 04:05 pm | KURA ONCOLOGY, INC.: Q1 2024 Earnings Release |
2024-05-02 04:05 pm | ZYMEWORKS INC.: Q1 2024 Earnings Release |
2024-05-02 04:02 pm | ARDELYX, INC.: Q1 2024 Earnings Release |
2024-05-02 04:01 pm | LONGBOARD PHARMACEUTICALS, INC.: Q1 2024 Earnings Release |
2024-05-02 04:01 pm | ASCENDIS PHARMA A/S: Q1 2024 Earnings Release |
2024-05-02 04:00 pm | ULTRAGENYX PHARMACEUTICAL INC.: Q1 2024 Earnings Release |
2024-05-02 11:00 am | GENMAB A/S: Q1 2024 Earnings Release |
2024-05-02 07:00 am | GERON CORPORATION: Q1 2024 Earnings Release |
2024-05-02 07:00 am | AGIOS PHARMACEUTICALS, INC.: Q1 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- CELC Stock
- Calendar Celcuity Inc.